TGFB1 and atrial fibrillation: To evaluate whether the cardiomyocytes and fibroblasts of IR hearts present factors favoring AF-related pathophysiology, we established in vitro IR models by treating neonatal mouse cardiomyocytes and rat atrial fibroblasts with palmitate, and we evaluated the expression of TGF-β1.